Leonabio, Inc. · NASDAQ:LONA
Anders Hove reported a 12.10% stake in Leonabio, Inc. (Schedule 13G/A)
Event Aug 18, 2026 · Filed Aug 20, 2026
Anders Hove reported a 12.10% stake in Leonabio, Inc., 1,492,521 shares, as a passive investor on Aug 18, 2026. Filed Aug 20, 2026 (Schedule 13G/A).
- Stake
- 12.10%
- Shares
- 1,492,521
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 5.10% | 480,653 |
| ACORN CAPITAL ADVISORS GP, LLC | 5.10% | 480,653 |
| ACORN BIOVENTURES 2, L.P. | 7.00% | 663,763 |
| Acorn Capital Advisors GP 2, LLC | 7.00% | 663,763 |
| Anders Hove | 12.10% | 1,492,521 |
Source
Related
- Leonabio, Inc.
- Anders Hove
- Leonabio, Inc. shareholders
- Schedule 13G/A · Anders Hove · Jan 8, 2026
- Schedule 13G · Anders Hove · Dec 23, 2025
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026